NEURAXIS, INC.
Last · NYSE$6.53+0.03 (+0.46%)close · yahoo · 17h ago
Vol 173.1K ≈ 1.13M
MA10MA20MA50
Market cap$82.00M12.6M sh
P/E · TTM-8.4fwd -24.2 · eps -0.78 · loss
Beta1.36vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.21$9.33
Volume173.1Ksession
Issuer
Legal nameNEURAXIS, INC.
HQUnited States (US)
ListingUS NRXS
ISINUS64134X2018
SectorHealthcare
IndustryHealthcare Products
SIC3845
CurrencyUSD
Entity registrysec:0001933567
CIK0001933567
Websitewww.neuraxis.com
Employees24
AddressNeurAxis, Inc. 11611 North Meridian Street 46032, Carmel
| Revenue | $3.5M |
|---|---|
| Operating income | $-3.9M |
| Net income | $-4.2M |
| Free cash flow | $-2.3M |
| Operating margin | -109.3% |
| Net margin | -119.6% |
| Return on equity | -62.8% |
| Period | 2026 |
Loading chart…
Earnings transcripts
Press & signals
- GlobeNewswire
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
- GlobeNewswire
NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth
Documents
FormReporting forFiledFlags
Showing 5 of 10 filings